May 2018
-
05.31.2018 Partnerships Cortexyme Completes $76 Million Series B Financing and Provides Update on Clinical Development Progress -
05.08.2018 Partnerships XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery -
05.08.2018 Partnerships New project to enhance nanomedicine development -
05.07.2018 Partnerships Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer -
05.01.2018 Partnerships HUB Announces Collaboration with Pfizer Inc. on Human Gut Organoids for IBD
March 2018
-
03.19.2018 Partnerships BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent -
03.12.2018 Partnerships BIOGEN TO ACQUIRE FROM PFIZER FIRST-IN-CLASS PHASE 2b READY ASSET FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA -
03.09.2018 Partnerships AM‐Pharma announces Phase II study results of recAP in sepsis‐associated Acute Kidney Injury -
03.02.2018 Partnerships Neofluidics Announces Collaboration with Pfizer Inc.
February 2018
-
02.28.2018 Partnerships Inserm announces research agreement with Pfizer Inc. to study rare neuromuscular disease